Zhejiang NHU Co Ltd
Research Zhejiang NHU Co Ltd (002001.SZ) on Bullrun: market cap CNY 80.34B, P/E 11.2, dividend yield 3.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker002001.SZ
- ExchangeSZ
- CountryChina
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyCNY
- Market capCNY 80.34B
- P/E11.2
- Dividend yield3.8%
- Financial periodQ2 2026
- RevenueCNY 6.83B
- Net incomeCNY 2.18B
- Free cash flowCNY 935.13M
- Gross margin45.5%
Valuation Snapshot
latest market cap is CNY 80.34B; P/E is 11.2; dividend yield is 3.8%.
Peer valuation comparison
Latest P/E is 11.17x versus a Healthcare sector median of 21.75x (48.6% below).
Latest dividend yield is 3.83% versus a Healthcare sector median of 2.4% (59.6% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 80.34B | 11.2 | 3.8% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1 CNY, yield 3.8%.
About Zhejiang NHU Co Ltd
Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments. The company offers animal nutrition products comprising vitamins, amino acids, and carotenoids for poultry, swine, ruminants, and farmed fish;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zhejiang NHU Co Ltd's market cap?
Zhejiang NHU Co Ltd's market capitalization is CNY 80.34B.
What is Zhejiang NHU Co Ltd's P/E ratio?
Zhejiang NHU Co Ltd's price-to-earnings (P/E) ratio is 11.2.
Does Zhejiang NHU Co Ltd pay a dividend?
Zhejiang NHU Co Ltd has a dividend yield of 3.8%.
What does Zhejiang NHU Co Ltd do?
Zhejiang NHU Company Ltd., together with its subsidiaries, produces and sells nutritional products, fragrances and flavors, polymer materials, and active pharmaceutical ingredients in China and internationally. It operates through Pharmaceutical and Chemical; and Other segments.